{"id":"https://openalex.org/W4399323703","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074","title":"Identifying mutations in ctDNA to predict antibody-drug conjugate response in breast cancer.","display_name":"Identifying mutations in ctDNA to predict antibody-drug conjugate response in breast cancer.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399323703","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e13074","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048315523","display_name":"Luis E Chinea","orcid":"https://orcid.org/0000-0003-3511-2830","observed_orcids":["https://orcid.org/0000-0003-3511-2830"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luis Chinea","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027836515","display_name":"Isaac S. Chan","orcid":"https://orcid.org/0000-0003-2623-3163","observed_orcids":["https://orcid.org/0000-0003-2623-3163"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isaac Chan","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032184748","display_name":"Hannah Lu Chang","orcid":"https://orcid.org/0000-0002-1090-9838","observed_orcids":["https://orcid.org/0000-0002-1090-9838"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Chang","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"e13074","last_page":"e13074"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9079999923706055},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7950000166893005},{"id":"https://openalex.org/keywords/apobec-mutational-signature","display_name":"APOBEC mutational signature","score":0.7889999747276306},{"id":"https://openalex.org/keywords/erbb-signaling-pathway","display_name":"ErbB signaling","score":0.8629999756813049},{"id":"https://openalex.org/keywords/p53-signaling-pathway","display_name":"p53 pathway","score":0.8949999809265137},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7630000114440918},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.9819999933242798},{"id":"https://openalex.org/keywords/sacituzumab-govitecan","display_name":"sacituzumab govitecan","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8527019619941711},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.6977123022079468},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6207841634750366},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.578737199306488},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5717306137084961},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4724833369255066},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.45264625549316406},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41542771458625793},{"id":"https://openalex.org/C2781335228","wikidata":"https://www.wikidata.org/wiki/Q19596321","display_name":"Circulating tumor DNA","level":3,"score":0.41453588008880615},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39885246753692627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36349576711654663},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3246181607246399},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2846752405166626},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18791687488555908},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.e13074","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13074","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396591877","https://openalex.org/W4280609115","https://openalex.org/W4411286519","https://openalex.org/W2978176517","https://openalex.org/W2946096095","https://openalex.org/W7165042248","https://openalex.org/W3091195356","https://openalex.org/W3137996554","https://openalex.org/W2804369732","https://openalex.org/W3128814071"],"abstract_inverted_index":{"e13074":[0],"Background:":[1],"Metastatic":[2,151],"breast":[3,32,78],"cancer":[4,33,79],"(mBC)":[5],"is":[6,41],"a":[7,72,144,178,202,375],"complex":[8],"disease,":[9],"and":[10,46,110,200,216,224,232,241,267,319,346,428,446],"outcomes":[11],"remain":[12],"poor":[13],"because":[14,387],"new":[15,20,405],"therapies":[16,40,94],"are":[17,385,390,418,435],"needed.":[18],"A":[19],"class":[21],"of":[22,58,66,100,146,156,187,269,276,313,362,396,423,431],"drugs,":[23],"antibody-drug":[24],"conjugate":[25],"(ADC),":[26],"has":[27,85],"shown":[28],"effectiveness":[29],"across":[30],"all":[31],"subtypes.":[34,48],"Yet":[35],"FDA-":[36],"approval":[37],"for":[38,95,229,246,404],"these":[39],"restricted":[42],"only":[43],"to":[44,53,62,76,91,115,118,138,192,328,407,412,437,449],"HER2":[45,307,332,397],"triple-negative":[47],"Therefore,":[49],"we":[50,126],"urgently":[51],"need":[52,403],"identify":[54],"which":[55,409],"patients,":[56],"regardless":[57,395],"subtype,":[59],"will":[60],"respond":[61],"ADCs.":[63,140,382],"The":[64,112,173],"advent":[65],"circulating":[67],"tumor":[68],"DNA":[69],"(ctDNA)":[70],"offers":[71],"unique":[73],"noninvasive":[74],"method":[75],"capture":[77],"(BC)":[80],"heterogeneity.":[81],"Recently,":[82],"ctDNA":[83,131,162,170,188,371,426],"testing":[84,163,427],"been":[86],"employed":[87],"in":[88,98,108,121,190,355],"clinical":[89,113],"practice":[90],"guide":[92],"targeted":[93,392],"mBC,":[96,360],"particularly":[97],"cases":[99],"hormone":[101],"receptor":[102],"positive":[103],"(HR+)":[104],"disease":[105],"with":[106,158,220,254,330,337,366,374,381,393,425],"mutations":[107,134,197,445],"PIK3CA":[109],"ESR1.":[111],"implications":[114],"predict":[116,136],"response":[117,137,231,378,448],"ADC":[119,230,272,280,288,302,450],"therapy":[120,281,289],"BC":[122,226],"remains":[123],"unclear.":[124],"Here":[125],"test":[127,245],"the":[128,149,165,184,264,297,367,402,421,439],"hypothesis":[129],"that":[130,135],"can":[132],"detect":[133],"novel":[139],"Methods:":[141],"We":[142,194,250],"analyzed":[143,176],"subset":[145],"patients":[147,157,199,253,277,299,314,329,411,424],"from":[148,177,198],"Dallas":[150],"Breast":[152],"Cancer":[153],"Study":[154],"comprised":[155],"mBC":[159,256],"who":[160,257,278,300],"underwent":[161],"using":[164,205,239],"Tempus":[166],"xF":[167],"liquid":[168],"biopsy":[169],"sequencing":[171],"panel.":[172],"data":[174],"was":[175,326,372],"single":[179],"academic":[180],"medical":[181],"center":[182],"between":[183,442],"initial":[185],"year":[186],"collection":[189],"2019":[191],"2023.":[193],"identified":[195,251],"detectable":[196],"addressed":[201],"relationship":[203],"by":[204,370,420],"Metascape.":[206],"Relevant":[207],"signaling":[208],"pathways":[209,348],"were":[210,227,237],"identified:":[211],"APOBEC,":[212],"ErbB":[213,344],"signaling,":[214,345],"p53":[215,347],"Ras-MAPK":[217,265,368,443],"pathway.":[218],"Patients":[219,336],"triple":[221],"negative,":[222],"HER2,":[223],"HR":[225],"examined":[228],"associated":[233,365,373],"mutations.":[234],"Survival":[235],"analyses":[236],"estimated":[238],"Kaplan-Meier":[240],"Gehan":[242],"Breslow":[243],"Wilcoxon":[244],"statistical":[247],"analysis.":[248],"Results:":[249],"43":[252,270],"HR+":[255,359,388,410],"had":[258,305],"at":[259,338],"least":[260,339],"one":[261,340],"mutation":[262,341],"within":[263,342],"pathway":[266,369,444],"10":[268],"received":[271,279,301,315,321],"therapy.":[273],"Median":[274],"survival":[275],"58":[282],"months":[283,291],"(n=10)":[284],"vs":[285],"not":[286,350],"receiving":[287],"33":[290],"(n=33)":[292],"(p":[293],"<":[294],"0.05).":[295],"Of":[296],"ten":[298],"treatment,":[303],"60%":[304],"1+":[306],"staining":[308,333],"on":[309,334],"tissue":[310],"biopsy.":[311,335],"70%":[312],"Trastuzumab":[316],"deruxtecan":[317],"(T-DXd)":[318],"30%":[320],"Sacituzumab":[322],"govitecan":[323],"(SG).":[324],"SG":[325],"given":[327],"negative":[331],"ABOBEC,":[343],"did":[349],"have":[351],"statistically":[352],"significant":[353],"differences":[354],"mOS.":[356],"Conclusions:":[357],"In":[358],"detection":[361],"mutated":[363],"genes":[364],"more":[376],"favorable":[377,447],"when":[379],"treated":[380],"These":[383],"findings":[384,417],"exciting":[386],"BCs":[389],"being":[391],"ADCs":[394],"or":[398],"TROP2":[399],"expression,":[400],"highlighting":[401],"biomarkers":[406],"distinguish":[408],"treat.":[413],"Our":[414],"retrospective":[415],"analysis":[416],"limited":[419],"number":[422],"also":[429],"timing":[430],"testing.":[432],"Further":[433],"studies":[434],"needed":[436],"solidify":[438],"observed":[440],"correlation":[441],"treatment.":[451]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2024-06-05T00:00:00"}